Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Net Margin (2020 - 2021)

Rapid Therapeutic Science Laboratories' Net Margin history spans 2 years, with the latest figure at 2024678.33% for Q4 2021.

  • For Q4 2021, Net Margin changed N/A year-over-year to 2024678.33%; the TTM value through Sep 2022 reached 5097453.33%, down 511653096.0%, while the annual FY2021 figure was 537056.74%, 53548923.0% down from the prior year.
  • Net Margin for Q4 2021 was 2024678.33% at Rapid Therapeutic Science Laboratories, down from 1166884.0% in the prior quarter.
  • Across five years, Net Margin topped out at 486.99% in Q1 2020 and bottomed at 2024678.33% in Q4 2021.